Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mannitol × Breast × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 6 Genitourinary 3 Sarcoma 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 601 Paclitaxel 590 Cyclophosphamide 550 Docetaxel 490 Capecitabine 426 Letrozole 353 Carboplatin 336 Fulvestrant 328 Doxorubicin 288 Tamoxifen 255 pembrolizumab 234 Anastrozole 212 Epirubicin 211 exemestane 201 Radiotherapy 194 Bevacizumab 191 pertuzumab 187 Gemcitabine 183 Vinorelbine 170 Lapatinib 162 palbociclib 154 130-nm albumin-bound paclitaxel 145 Albumin-Bound Paclitaxel 137 Magnetic Resonance Spectroscopy 133 Exercise 127 eribulin 126 Fluorouracil 114 Taxes 113 Everolimus 102 Cisplatin 101

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06768268 2025-04-16

ICGMV

National Taiwan University Hospital

Phase 1/2 Enrolling by invitation

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡